Cover Image

Right Ventricular Dysfunction is related with Poor Exercise Tolerance in Elderly Patients with Heart Failure with Preserved Ejection Fraction

<p><strong>Background</strong>: Exercise intolerance (EI) is a cardinal feature in subjects with heart failure with preserved ejection fraction (HFpEF). Factors related to EI in such patients are not completely understood. The association between right ventricular (RV) dysfunction...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chiara Fossati (Author), Valentino D'Antoni (Author), Jeganath Murugesan (Author), Deborah Fortuna (Author), Serena Selli (Author), Noemi Punzo (Author), Giuseppe Caminiti (Author)
Format:	Book
Published:	Journal of Novel Physiotherapy and Physical Rehabilitation - Peertechz Publications, 2017-01-23.
Subjects:	Research Article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

DIASTOLIC LEFT VENTRICULAR DYSFUNCTION AND HEART FAILURE WITH PRESERVED EJECTION FRACTION IN ELDERLY
by: CALENICI Oleg, et al.
Published: (2022)

Beta-blockers in chronic heart failure with preserved left ventricular ejection fraction: is deprescribing possible?
by: V. D. Zakiev, et al.
Published: (2023)

Assessing cardiac contractility in hypertension with heart failure with preserved ejection fraction: the value of left ventricular strain
by: Simon W. Rabkin
Published: (2023)

Heart Failure with Preserved Left Ventricular Ejection Fraction: A Complex Conundrum Simply Not Limited to Diastolic Dysfunction
by: Angel Lopez-Candales, et al.
Published: (2023)

Effects of Progressive Muscular Relaxation Combined With Aerobic Continuous Training on Exercise Tolerance, Hemodynamics, and Life Quality in Patients with Chronic Heart Failure
by: Franchini Alessio, et al.
Published: (2014)

Study of correlation between right ventricular ejection fraction with left ventricular ejection fraction in patients of chronic heart failure with diabetes, using two-dimensional echocardiography
by: Vandan Shah, et al.
Published: (2024)

Pediatric heart failure with preserved ejection fraction, a review
by: Sophie Quennelle, et al.
Published: (2023)

Pediatric heart failure classification based on left ventricular ejection fraction
by: Shan Huang, et al.
Published: (2023)

Left ventricular thrombus formation in a patient with normal ejection fraction
by: Nihan Kahya Eren, et al.
Published: (2013)

Understanding cardiac systolic performance beyond left ventricular ejection fraction
by: Elena-Laura Antohi, et al.
Published: (2020)

NADPH Oxidases in Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction
by: James P. Teuber, et al.
Published: (2022)

Heart failure with preserved ejection fraction (HFpEF): Implications for the anesthesiologists
by: Ajmer Singh, et al.
Published: (2018)

Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR‐Preserved
by: Andrew J.S. Coats, et al.
Published: (2024)

Outcome of angiotensin receptor-neprilysin inhibitor on anxiety and depression in heart failure with reduced ejection fraction vs. heart failure with preserved ejection fraction
by: Jahanzeb Malik, et al.
Published: (2021)

FEATURES OF CEREBRAL HEMODYNAMICS AND MANIFESTATIONS OF HEPATIC ENCEPHALOPATHY IN CIRRHOSIS OF VIRAL ETIOLOGY AT DIFFERENT COMPENSATION STAGES WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION
by: V. E. Kulikov, et al.
Published: (2017)

The impact of renal tubulointerstitial dysfunction on the early and long-term prognosis in chronic heart failure patients with preserved left ventricular ejection fraction
by: V. V. Syvolap, et al.
Published: (2024)

THE ROLE OF FACTORS AFFECTING THE FORMATION OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION
by: M. V. Kurkina, et al.
Published: (2017)

Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors
by: Artem Ovchinnikov, et al.
Published: (2022)

Mitochondrial Reactive Oxygen Species Dysregulation in Heart Failure with Preserved Ejection Fraction: A Fraction of the Whole
by: Caroline Silveira Martinez, et al.
Published: (2024)

Adenine-Induced Chronic Renal Failure in Rats: A Model of Chronic Renocardiac Syndrome with Left Ventricular Diastolic Dysfunction but Preserved Ejection Fraction
by: Pavlos Kashioulis, et al.
Published: (2018)

Noninvasive imaging assessment of rehabilitation therapy in heart failure with preserved and reduced left ventricular ejection fraction (IMAGING-REHAB-HF): design and rationale
by: Fernando Bianchini Cardoso, et al.
Published: (2019)

Myoglobin and left ventricular ejection fraction as predictive markers for death in children with fulminant myocarditis
by: Tingting Xie, et al.
Published: (2022)

Close association of arterial plaques with left ventricular hypertrophy and ejection fraction in hemodialysis patients
by: Mowlaie Morteza, et al.
Published: (2014)

The relationship between abdominal fat and change in left ventricular ejection fraction in cancer patients
by: Kerryn W. Reding, et al.
Published: (2021)

ALGORITHM FOR THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION
by: E. V. Reznik, et al.
Published: (2018)

Laboratory changes and prognostic indicators of the adverse course of chronic heart failure with preserved left ventricular ejection fraction, excess weight and concomitant atrial fibrillation
by: P. P. Bidzilya, et al.
Published: (2023)

Dapagliflozin versus sacubitril-valsartan for heart failure with mildly reduced or preserved ejection fraction
by: Ronen Arbel, et al.
Published: (2024)

ATRIAL FIBRILLATION AND ARTERIAL HYPERTENSION: GENDER DIFFERENCES OF VENTRICULOATRIAL REMODELING WITH PRESERVED EJECTION FRACTION
by: Zh. D. Kobalava, et al.
Published: (2017)

Pharmacological Tuning of Adenosine Signal Nuances Underlying Heart Failure With Preserved Ejection Fraction
by: Alexandrina Campos-Martins, et al.
Published: (2021)

Up-Titration of Sacubitril/Valsartan Among Patients With Heart Failure and Preserved Ejection Fraction
by: Koichiro Matsumura MD, et al.
Published: (2023)

The Role of Sodium-Glucose Cotransporter-2 Inhibition in Heart Failure with Preserved Ejection Fraction
by: Lindsay Brust-Sisti, et al.
Published: (2022)

Association Between Hyperaldosteronemia and Electrophysiological Myocardial Activity in Heart Failure with Preserved Ejection Fraction
by: A. N. Shevelok
Published: (2020)

Left Ventricular Remodeling Risk Predicted by Two-Dimensional Speckle Tracking Echocardiography in Acute Myocardial Infarction Patients with Midrange or Preserved Ejection Fraction in Western Romania
by: Bordejevic DA, et al.
Published: (2021)

Features of structural and geometric remodeling of the heart and changes in the diastolic filling of the heart in patients with chronic heart failure of ischemic genesis with preserved left ventricular ejection fraction
by: V. A. Lysenko, et al.
Published: (2021)

Wild type transthyretin cardiac amiloidozis as a rare and overlooked underlying etiology in a patient with heart failure with preserved ejection fraction and left ventricular hypertrophy
by: Selda Murat, et al.
Published: (2021)

Malondialdehyde Serum Levels in Patients with Systemic Sclerosis Relate to Dyslipidemia and Low Ventricular Ejection Fraction
by: Zeina Ibrahim-Achi, et al.
Published: (2023)

Rehabilitation outcomes of stroke patients with low left ventricular ejection fraction in the subacute rehabilitation phase
by: Masahiro Tsujikawa, et al.
Published: (2018)

Impact of the recovery of left ventricular ejection fraction after TAVI on mortality in patients with aortic stenosis
by: Barış Kılıçaslan, et al.
Published: (2021)

Heart Failure with Preserved Ejection Fraction in a Postpartum Patient with Superimposed Preeclampsia and COVID-19
by: Rachel G. Sinkey, et al.
Published: (2020)

Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis
by: Marlies Antlanger, et al.
Published: (2017)